Switzerland· 47836001
Valverde Herz und Nerven, Filmtabletten
A other cardiac combination products product, registered in Switzerland by Uriach Switzerland AG and dispensed under Swissmedic category D. The same ATC class is registered in 3 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Valverde is registered in 3 of 19 countries.
Countries holding a registration under ATC C01EX (other cardiac combination products), each read from that country’s own register.
- This record: Switzerland
- 3 of them publish a price we can compare per daily dose
Valverde · ATC C01EX
3 / 19 countries
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Uriach Switzerland AG
- Country
- Switzerland (CH)
- ATC code
- C01EX
- ATC class
- Other cardiac combination products
- Swissmedic category
- D
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C01EX
Other cardiac combination products, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6dbfe43-90a9-47d5-8fe9-ab9c09930a39 GET /v1/drugs/c6dbfe43-90a9-47d5-8fe9-ab9c09930a39?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Phytoarzneimittel"
}See everything about Valverde.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.